Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · IEX Real-Time Price · USD
9.75
-0.79 (-7.50%)
At close: Apr 19, 2024, 4:00 PM
9.76
+0.01 (0.10%)
After-hours: Apr 19, 2024, 5:53 PM EDT
Astria Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Astria Therapeutics stock have an average target of 21.75, with a low estimate of 17 and a high estimate of 27. The average target predicts an increase of 123.08% from the current stock price of 9.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ATXS stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $17 | Buy | Maintains | $17 | +74.36% | Mar 26, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $22 → $27 | Strong Buy | Maintains | $22 → $27 | +176.92% | Mar 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 | Strong Buy | Maintains | $18 | +84.62% | Mar 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +84.62% | Mar 14, 2024 |
| Wedbush | Wedbush | Buy Reiterates $17 | Buy | Reiterates | $17 | +74.36% | Mar 5, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.58
from -2.42
EPS Next Year
-1.77
from -1.58
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | 5.3M |
| Avg | n/a | n/a | 1.0M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.28 | -1.48 | -1.55 |
| Avg | -1.58 | -1.77 | -1.77 |
| Low | -1.87 | -2.05 | -2.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.